No exploitation reportedFix available

CVE-2019-13517

No exploitation reported by the sources we read.

Published2019-09-06
WeaknessCWE-384

Am I affected?

With a domain, we read the version its public headers and pages expose. A distribution build can carry the fix under an older number.

Description

In Pyxis ES Versions 1.3.4 through to 1.6.1 and Pyxis Enterprise Server, with Windows Server Versions 4.4 through 4.12, a vulnerability has been identified where existing access privileges are not restricted in coordination with the expiration of access based on active directory user account changes when the device is joined to an AD domain.

Timeline

dates in UTC

2019-09-0614:15CVE publishedNVD

Observed activity

isMalicious corpus · updated 2026-10-23 21:37 UTC

Indicators tagged with this CVE, per day0 indicators over 7 days

Block these indicators

Firewall list (EDL, text): https://api.ismalicious.com/edl/cve/CVE-2019-13517?format=txt
CSV export: https://api.ismalicious.com/edl/cve/CVE-2019-13517?format=csv
TAXII collection of exploited CVEs
The EDL and CSV take an API key on the Pro plan.

Versions per branch

NVD

Bd pyxis enterprise server

Branch	Affected	Fixed in	Source
4.x	≥ 4.4, ≤ 4.12	no fix published	NVD

Bd pyxis es

Branch	Affected	Fixed in	Source
1.x	≥ 1.3.4, ≤ 1.6.1	no fix published	NVD

as publishedRanges as NVD and OSV publish them; a distribution’s build can be fixed under an older number.

Distribution builds and vendor advisories

Packages from OSV.dev and products from the vendors' CSAF advisories.

version not verifiedVersions not verified: read as OSV.dev and the vendors publish them, not checked against each vendor's release list.

Vendor advisories

ICSMA-19-248-01 CISA2 known affected
BD Pyxis (Update A)
Pyxis ES Versions 1.3.4 through to 1.5.3 · Pyxis Enterprise Server with Windows Server: Versions 4.4 through 4.12

Full record on NVD

Fix

Vendor fix CISA ICSMA-19-248-01 · 2 productsBD notes that connecting medication dispensing cabinets to a hospital domain is an uncommon configuration and is not recommended. BD reports this vulnerability was remediated in the latest software release; however, BD has been unsuccessful in reproducing this issue since initially testing and repr…

Advisories and patches

www.us-cert.govMitigation

Detection

Nuclei template: none so far
Exploit-DB: no entry
Proof-of-concept repositories: none listed

Sources

NVDCVSS 3.08.8read 2026-10-23
NVDCVSS 2.06.5read 2026-10-23
CNAweakness (CWE)CWE-384read 2026-10-23
NVDweakness (CWE)CWE-384read 2026-10-23
FIRST EPSSEPSS score1.3 %2026-10-23

Technical details

CVSS v3 Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Published: 2019-09-06
Last Modified: 2026-06-17
NVD status: Modified

Frequently asked questions

What is CVE-2019-13517?

Is CVE-2019-13517 actively exploited?

Active exploitation of CVE-2019-13517 has not been confirmed. Its EPSS score was 1.3% on 2026-10-23, the estimated probability of exploitation in the next 30 days.

What is the CVSS score for CVE-2019-13517?

CVE-2019-13517 has a CVSS v3 base score of 8.8 (HIGH severity), with vector string CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Running BD Pyxis? Hear about its next vulnerability

Surveillance reads the versions in your stack — a domain, a lockfile or a list — checks each CVE against the ranges its sources publish, and alerts you when one you run is exploited or enters CISA KEV. A version it cannot read stays « version not verified ».

Get alerts for this product CISA KEV additions, October 2026 Search CVEs

No credit card required · No monthly cap on website lookups · 250 API requests/month

Go further

Following what attackers exploit right now? The CISA KEV additions of the month, with their patch deadlines.
Running this software? Vulnerability monitoring alerts you to new vulnerabilities in your products.

Related vulnerabilities

Same product first, then the same vendor advisory and the same publication week.

Back to CVE Database